Article
The BIOSECURE Act Becomes Law (Japanese)
2025年12月18日、トランプ大統領は...
Morrison & Foerster LLP
Japan: Food, Drugs, Healthcare, Life Sciences
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
The BIOSECURE Act Becomes Law
On December 18, 2025, President Trump signed into law the BIOSECURE Act as part of the National Defense Authorization Act (NDAA), which is the U.S. Congress's annual defense policy bill.
Morrison & Foerster LLP
Article
Japan's AMED Offers 'Double Match Up' Grants For Pharma Startups: Considerations For Investors And Companies
The Japanese government is aware of the challenges in securing funds for drug development within Japan's biopharmaceutical startup ecosystem, especially compared to Europe and the United States.
Greenberg Traurig, LLP
Article
Biosimilar Manufacturers To Expand Offerings In Europe And Japan
On June 9, 2025, biosimilar manufacturers Samsung Bioepis and Alvotech announced separate deals to expand their respective offerings in Japan and Europe.
Goodwin Procter LLP
Article
Life Science Newsletter May 2025
Anderson Mori & Tomotsune
Article
Life Science Newsletter April 2025
Anderson Mori & Tomotsune
Article
Life Science Newsletter April 2025 (Japanese)
Anderson Mori & Tomotsune
Article
Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan
Oh-Ebashi LPC & Partners
Article
Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"
Anderson Mori & Tomotsune
Article
「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁 止法関係事例集」の公表
Anderson Mori & Tomotsune
Article
Innovative 3D Printing In Healthcare: From Design To Drug Delivery
Marks & Clerk
Article
Life Science Newsletter February 2025 (Japanese)
Anderson Mori & Tomotsune
Article
Life Science Newsletter February 2025
Anderson Mori & Tomotsune
Article
Life Science Newsletter (January 2025)
Anderson Mori & Tomotsune
Article
The Chemistry Controls The Calendar: Predictive Testing, Design Around Reformulations & The Cost Of Racing To Trial In Kaneka Corp. V. Designs For Health
YMF Law Tokyo
Article
Japan Shifts To Next‑Generation Space Transportation Regulation With Space Activities Act Amendment
Greenberg Traurig, LLP
Article
SANAE TOKEN: Japan's Meme-Coin Scare
Caldwell
Article
Why Global Asset Managers Are Increasingly Focusing On Japan
Maples Group
Article
Japan’s Sovereign Cloud Commitment At The U.S.-Japan Summit: Defense Interoperability, Not Just Digital Policy
Crowell & Moring LLP
Article
The BIOSECURE Act Becomes Law (Japanese)
2025年12月18日、トランプ大統領は...
Morrison & Foerster LLP
Article
The BIOSECURE Act Becomes Law
On December 18, 2025, President Trump signed into law the BIOSECURE Act as part of the National Defense Authorization Act (NDAA), which is the U.S. Congress's annual defense policy bill.
Morrison & Foerster LLP
Article
The "Paper NDA" Problem: When Bifurcation Of Rico And Patent Claims Defeats Hatch-Waxman's Purpose
In mid-June 2025, attorneys for plaintiffs Janssen Products and PharmaMar were reviewing their opponent's document production in a routine Hatch-Waxman patent...
YMF Law Tokyo
Article
Japan's AMED Offers 'Double Match Up' Grants For Pharma Startups: Considerations For Investors And Companies
Greenberg Traurig, LLP
Article
まさかの特許バトル：たったこれだけの投与変更が数十億ドルに
YMF Law Tokyo
Article
Not So Obvious: You Won't Believe How This Simple Dosing Change Became Worth Billions
YMF Law Tokyo
Article
Life Science Newsletter April 2025
Anderson Mori & Tomotsune
Article
Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan
Oh-Ebashi LPC & Partners
Article
Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"
Anderson Mori & Tomotsune
Article
Genus Claiming (Including Means Plus Function “MPF” Claiming) In Biotech And Pharma: Doctrinal Trajectory And Drafting Strategies
Finnegan attorney Chiaki Kobayashi explores the complex landscape of genus claiming in biotechnology and pharmaceutical patents, examining doctrinal developments and practical drafting approaches. The article, edited by partner John D. Livingstone, provides strategic guidance for navigating means-plus-function claiming methodologies in life sciences intellectual property.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Article
The BIOSECURE Act Becomes Law (Japanese)
2025年12月18日、トランプ大統領は...
Morrison & Foerster LLP
Article
The BIOSECURE Act Becomes Law
On December 18, 2025, President Trump signed into law the BIOSECURE Act as part of the National Defense Authorization Act (NDAA), which is the U.S. Congress's annual defense policy bill.
Morrison & Foerster LLP
Article
Japan's AMED Offers 'Double Match Up' Grants For Pharma Startups: Considerations For Investors And Companies
Greenberg Traurig, LLP
Article
The CRISPR Patent Wars Hit Japan: A High-Stakes Battle Over Gene-Editing's Future
YMF Law Tokyo
Article
Biosimilar Manufacturers To Expand Offerings In Europe And Japan
Goodwin Procter LLP
Article
Life Science Newsletter May 2025
Anderson Mori & Tomotsune
Article
Life Science Newsletter April 2025
Anderson Mori & Tomotsune
Article
Life Science Newsletter April 2025 (Japanese)
Anderson Mori & Tomotsune
Article
The BIOSECURE Act Becomes Law (Japanese)
2025年12月18日、トランプ大統領は...
Morrison & Foerster LLP
Article
The BIOSECURE Act Becomes Law
On December 18, 2025, President Trump signed into law the BIOSECURE Act as part of the National Defense Authorization Act (NDAA), which is the U.S. Congress's annual defense policy bill.
Morrison & Foerster LLP
Article
Life Science Newsletter April 2025
The Ministry of Health, Labour and Welfare (MHLW) and the Ministry of Economy, Trade and Industry (METI) have revised the Guidelines for New Business Activities in the Healthy Life Extension Industry Sector...
Anderson Mori & Tomotsune
Article
Life Science Newsletter April 2025 (Japanese)
Anderson Mori & Tomotsune
Article
Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan
Oh-Ebashi LPC & Partners
Article
Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"
Anderson Mori & Tomotsune
Article
「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁 止法関係事例集」の公表
Anderson Mori & Tomotsune
Article
Innovative 3D Printing In Healthcare: From Design To Drug Delivery
Marks & Clerk
Article
Life Science Newsletter (January 2025)
Anderson Mori & Tomotsune
See more
Управляющий партнер KP Disputes Равиль Кассильгов выступил на конференции IP ЕВРАЗИЯ / IP КАЗАХСТАН'2025 (Video)
KP Disputes
Investment Trends In The Agricultural Industry (Video)
FTI Consulting
A Landmark Judgment On Altruistic Organ Donation (Video)
IndiaLaw LLP
Sidharrth Shankar | Indian Healthcare Sector In 2023 And Way Forward In 2024 (Video)
JSA
How To Export Cosmetics To Thailand (Video)
Tilleke & Gibbins